Floatz logo

Orlistat

Anovulation

Sheffield Teaching Hospitals NHS Foundation TrustSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Anovulation cohort.

Asset / SponsorPhaseRating
CLOMIPHENE CITRATE
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Phase 4BBB
Letrozole
GABRIEL MONTEIRO PINHEIRO
Phase 4BBB
Metformin
Ain Shams Maternity Hospital
Phase 4BBB
Recombinant Human Follicle Stimulating Hormone
University of California, San Diego
Phase 4BB
Folate
University Magna Graecia
Phase 4BB

View all 12 →

Same molecule, other indications

Orlistat is also rated in:

type 2 diabetes mellitusDormant
BBB
Indicative ·
73 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →
obesity disorderDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →